While effective for some, these approaches often fall short for individuals with underlying metabolic challenges, hormonal imbalances, or age-related barriers
Clinical trials used doses as high as 1 mg per day without safety concerns, but 300 mcg is the most commonly referenced dose in peptide medicine literature and in the investigational protocols that have been published since the formal trials concluded
Early research is mostly preclinical, so it should not be treated as a proven anti-aging or fat-loss treatment
Researched For AOD-9604 has been studied in vitro and in animal models for its influence on lipolytic pathways in fat cells, with researchers investigating how the peptide fragment interacts with adrenergic signaling to affect lipid mobilization
Blood tests, like serum B12 levels and complete blood counts, are key to making these decisions